Literature DB >> 14736873

Characterization of four autonomous repression domains in the corepressor receptor interacting protein 140.

Mark Christian1, Jennifer M A Tullet, Malcolm G Parker.   

Abstract

Receptor interacting protein (RIP) 140 is a corepressor that can be recruited to nuclear receptors by means of LXXLL motifs. We have characterized four distinct autonomous repression domains in RIP140, termed RD1-4, that are highly conserved in mammals and birds. RD1 at the N terminus represses transcription in the presence of trichostatin A, suggesting that it functions by a histone deacetylase (HDAC)-independent mechanism. The repressive activity of RD2 is dependent upon carboxyl-terminal binding protein recruitment to two specific binding sites. Use of specific inhibitors indicates that RD2, RD3, and RD4 are capable of functioning by HDAC-dependent and HDAC-independent mechanisms, depending upon cell type.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14736873     DOI: 10.1074/jbc.M313906200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  25 in total

1.  Nuclear receptor corepressor RIP140 regulates fat accumulation.

Authors:  Göran Leonardsson; Jenny H Steel; Mark Christian; Victoria Pocock; Stuart Milligan; Jimmy Bell; Po-Wah So; Gema Medina-Gomez; Antonio Vidal-Puig; Roger White; Malcolm G Parker
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-20       Impact factor: 11.205

2.  NIR is a novel INHAT repressor that modulates the transcriptional activity of p53.

Authors:  Philip Hublitz; Natalia Kunowska; Ulrich P Mayer; Judith M Müller; Kristina Heyne; Na Yin; Claudia Fritzsche; Cecilia Poli; Laurent Miguet; Ingo W Schupp; Leo A van Grunsven; Noëlle Potiers; Alain van Dorsselaer; Eric Metzger; Klaus Roemer; Roland Schüle
Journal:  Genes Dev       Date:  2005-12-01       Impact factor: 11.361

3.  RIP140 directs histone and DNA methylation to silence Ucp1 expression in white adipocytes.

Authors:  Evangelos Kiskinis; Magnus Hallberg; Mark Christian; Martina Olofsson; Stephen M Dilworth; Roger White; Malcolm G Parker
Journal:  EMBO J       Date:  2007-11-01       Impact factor: 11.598

4.  A functional interaction between RIP140 and PGC-1alpha regulates the expression of the lipid droplet protein CIDEA.

Authors:  Magnus Hallberg; Daniel L Morganstein; Evangelos Kiskinis; Kunal Shah; Anastasia Kralli; Stephen M Dilworth; Roger White; Malcolm G Parker; Mark Christian
Journal:  Mol Cell Biol       Date:  2008-09-15       Impact factor: 4.272

5.  Suppression of receptor interacting protein 140 repressive activity by protein arginine methylation.

Authors:  M D Mostaqul Huq; Pawan Gupta; Nien-Pei Tsai; Roger White; Malcolm G Parker; Li-Na Wei
Journal:  EMBO J       Date:  2006-10-19       Impact factor: 11.598

6.  Human Ccr4-Not complex is a ligand-dependent repressor of nuclear receptor-mediated transcription.

Authors:  G Sebastiaan Winkler; Klaas W Mulder; Vivian J Bardwell; Eric Kalkhoven; H Th Marc Timmers
Journal:  EMBO J       Date:  2006-06-15       Impact factor: 11.598

7.  Transcriptional Suppression by Transient Recruitment of ARIP4 to Sumoylated nuclear receptor Ad4BP/SF-1.

Authors:  Hidesato Ogawa; Tomoko Komatsu; Yasushi Hiraoka; Ken-Ichirou Morohashi
Journal:  Mol Biol Cell       Date:  2009-08-19       Impact factor: 4.138

8.  Molecular basis for repression of liver X receptor-mediated gene transcription by receptor-interacting protein 140.

Authors:  Tomas Jakobsson; Waffa Osman; Jan-Ake Gustafsson; Johanna Zilliacus; Anette Wärnmark
Journal:  Biochem J       Date:  2007-07-01       Impact factor: 3.857

9.  Lysine methylation of nuclear co-repressor receptor interacting protein 140.

Authors:  M D Mostaqul Huq; Sung Gil Ha; Helene Barcelona; Li-Na Wei
Journal:  J Proteome Res       Date:  2009-03       Impact factor: 4.466

Review 10.  RNAi screens reveal novel metabolic regulators: RIP140, MAP4k4 and the lipid droplet associated fat specific protein (FSP) 27.

Authors:  V Puri; J V Virbasius; A Guilherme; M P Czech
Journal:  Acta Physiol (Oxf)       Date:  2008-01       Impact factor: 6.311

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.